Mallinckrodt plc (NYSE:MNK)

CAPS Rating: 2 out of 5

Results 1 - 8 of 8

Recs

0
Member Avatar PrototypeZ (21.41) Submitted: 12/30/2015 2:08:33 PM : Underperform Start Price: $75.88 MNK Score: -0.30

Theory test: Poor performers for 2015 will continue to be poor performers in 2016

Recs

0
Member Avatar manirg (< 20) Submitted: 8/6/2015 12:05:53 PM : Outperform Start Price: $95.80 MNK Score: -17.97

undervalued

Recs

0
Member Avatar graybell (< 20) Submitted: 8/5/2015 3:23:31 PM : Outperform Start Price: $104.48 MNK Score: -22.88

oversold

Recs

0
Member Avatar foolmelgoner (65.74) Submitted: 1/26/2015 8:55:11 AM : Outperform Start Price: $106.58 MNK Score: -26.62

good acquisition target

Recs

0
Member Avatar benyboy (< 20) Submitted: 1/16/2015 9:54:13 AM : Outperform Start Price: $104.42 MNK Score: -27.68

cramer

Recs

0
Member Avatar awallejr (28.58) Submitted: 4/7/2014 12:07:46 PM : Outperform Start Price: $59.71 MNK Score: +14.57

QCOR buy out on the cheap.

Recs

1
Member Avatar domesticated (36.70) Submitted: 12/17/2013 1:22:42 PM : Outperform Start Price: $51.33 MNK Score: +30.16

Very undervalued spinoff.

Recs

0
Member Avatar estoces (< 20) Submitted: 8/3/2013 12:11:08 PM : Outperform Start Price: $45.51 MNK Score: +42.48

methadone - opiate treatment, need i say more.

Results 1 - 8 of 8

Featured Broker Partners